Madagascar vs Qatar: Access to anti-retroviral drugs, female
Madagascar
39.0%
in 2024
Qatar
43.0%
in 2024
Madagascar rank
128th
Qatar rank
126th
Access to anti-retroviral drugs, female over time
- Madagascar
- Qatar
How they compare
Qatar currently reports 43.0% against 39.0% in Madagascar, a difference of 4.0%.
That makes Qatar's figure about 1.1 times Madagascar's.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Qatar ahead.
Madagascar ranks 128th and Qatar ranks 126th of 141 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | Madagascar | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 0.0% | 0.1% | Madagascar |
| 2010s | 7.2% | 85.2% | 78.0% | Qatar |
| 2020s | 24.6% | 53.0% | 28.4% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Madagascar or Qatar?
- Qatar, at 43.0% against 39.0% in Madagascar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Madagascar and Qatar?
- 4.0%, with Qatar ahead.
- How many years of comparable data are there for Madagascar and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Madagascar and Qatar rank globally for access to anti-retroviral drugs, female?
- Madagascar ranks 128th and Qatar ranks 126th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.